It is proposed that these changes in chromatin architecture contribute to the pathogenesis of mutant-IDH driven AML by promoting self-renewal and repressing differentiation transcriptional networks [18,22,39,40,46]. The gene discussed is IDH2; the disease is acute myeloid leukemia.